BlackRock’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $211M | Buy |
4,737,519
+1,187,965
| +33% | +$56.3M | ﹤0.01% | 1764 |
|
|
2026
Q1 | $183M | Sell |
3,549,554
-1,294
| -0% | -$90.6K | ﹤0.01% | 1725 |
|
|
2025
Q4 | $327M | Buy |
3,550,848
+3,653
| +0.1% | +$350K | 0.01% | 1375 |
|
|
2025
Q3 | $263M | Sell |
3,547,195
-326,591
| -8% | -$33.1M | ﹤0.01% | 1505 |
|
|
2025
Q2 | $503M | Sell |
3,873,786
-155,773
| -4% | -$22.6M | 0.01% | 1048 |
|
|
2025
Q1 | $642M | Sell |
4,029,559
-171,774
| -4% | -$31.1M | 0.01% | 872 |
|
|
2024
Q4 | $779M | Buy |
4,201,333
+83,184
| +2% | +$16.1M | 0.02% | 782 |
|
|
2024
Q3 | $869M | Buy |
4,118,149
+2,260,233
| +122% | +$393M | 0.02% | 715 |
|
|
2024
Q2 | $249M | Sell |
1,857,916
-33,103
| -2% | -$6.26M | 0.01% | 1471 |
|
|
2024
Q1 | $406M | Buy |
1,891,019
+90,812
| +5% | +$17.8M | 0.01% | 1178 |
|
|
2023
Q4 | $366M | Sell |
1,800,207
-95,178
| -5% | -$15.4M | 0.01% | 1242 |
|
|
2023
Q3 | $376M | Buy |
1,895,385
+77,802
| +4% | +$19.6M | 0.01% | 1101 |
|
|
2023
Q2 | $590M | Sell |
1,817,583
-464,517
| -20% | -$133M | 0.02% | 830 |
|
|
2023
Q1 | $534M | Buy |
2,282,100
+146,344
| +7% | +$37M | 0.02% | 875 |
|
|
2022
Q4 | $538M | Buy |
2,135,756
+129,892
| +6% | +$27.7M | 0.02% | 835 |
|
|
2022
Q3 | $356M | Buy |
2,005,864
+104,573
| +6% | +$21M | 0.01% | 1050 |
|
|
2022
Q2 | $347M | Buy |
1,901,291
+57,406
| +3% | +$11.4M | 0.01% | 1119 |
|
|
2022
Q1 | $473M | Sell |
1,843,885
-2,342
| -0.1% | -$535K | 0.01% | 1029 |
|
|
2021
Q4 | $425M | Buy |
1,846,227
+38,582
| +2% | +$9.42M | 0.01% | 1160 |
|
|
2021
Q3 | $421M | Sell |
1,807,645
-98,186
| -5% | -$20.5M | 0.01% | 1124 |
|
|
2021
Q2 | $368M | Sell |
1,905,831
-96,385
| -5% | -$19.1M | 0.01% | 1291 |
|
|
2021
Q1 | $414M | Buy |
2,002,216
+8,502
| +0.4% | +$1.81M | 0.01% | 1170 |
|
|
2020
Q4 | $375M | Buy |
1,993,714
+91,563
| +5% | +$15M | 0.01% | 1112 |
|
|
2020
Q3 | $245M | Buy |
1,902,151
+133,064
| +8% | +$14.7M | 0.01% | 1217 |
|
|
2020
Q2 | $154M | Buy |
1,769,087
+665,523
| +60% | +$51.2M | 0.01% | 1546 |
|
|
2020
Q1 | $66.5M | Sell |
1,103,564
-730,655
| -40% | -$54.1M | ﹤0.01% | 1898 |
|
|
2019
Q4 | $136M | Sell |
1,834,219
-94,720
| -5% | -$6.09M | 0.01% | 1767 |
|
|
2019
Q3 | $118M | Buy |
1,928,939
+522,638
| +37% | +$34.4M | ﹤0.01% | 1796 |
|
|
2019
Q2 | $85.3M | Buy |
1,406,301
+426,425
| +44% | +$23M | ﹤0.01% | 2012 |
|
|
2019
Q1 | $55.6M | Buy |
979,876
+174,405
| +22% | +$9.42M | ﹤0.01% | 2214 |
|
|
2018
Q4 | $34M | Buy |
805,471
+259,453
| +48% | +$11M | ﹤0.01% | 2446 |
|
|
2018
Q3 | $23M | Sell |
546,018
-4,287
| -0.8% | -$201K | ﹤0.01% | 2795 |
|
|
2018
Q2 | $19.6M | Buy |
+550,305
| New | +$17.8M | ﹤0.01% | 2868 |
|
Other funds holding INSP
SCM
DM
BlackRock's INSP Position: Q2 2026 in Review
BlackRock increased its Inspire Medical Systems (INSP) stake by 33% in Q2 2026, buying an estimated $56.3M and bringing the position to 4,737,519 shares worth $211M. The position accounts for ﹤0.01% of the portfolio, ranked #1764.
BlackRock first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $869M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- BlackRock held 4,737,519 shares of Inspire Medical Systems worth $211M as of Q2 2026.
- BlackRock bought 1,187,965 Inspire Medical Systems shares in Q2 2026, an estimated $56.3M.
- Inspire Medical Systems made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1764 holding.
- BlackRock first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- BlackRock's Inspire Medical Systems position peaked at $869M in Q3 2024.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.